

Publisher: Future Medicine
ISSN: 1479-6694
Source: Future Oncology, Vol.4, Iss.2, 2008-04, pp. : 145-147
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Targeting T cells for GVHD therapy
By Vallera D.A.
Seminars in Cancer Biology, Vol. 7, Iss. 2, 1996-02 ,pp. :






Responses of T cells to ligands for the T-cell receptor
By Janeway Jr C.A. Bottomly K.
Seminars in Immunology, Vol. 8, Iss. 2, 1996-02 ,pp. :